Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;30(4):980-4.
doi: 10.1038/leu.2015.211. Epub 2015 Jul 31.

IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression

C D DiNardo  1 , E Jabbour  1 , F Ravandi  1 , K Takahashi  1 , N Daver  1 , M Routbort  2 , K P Patel  2 , M Brandt  1 , S Pierce  1 , H Kantarjian  1 , G Garcia-Manero  1
Affiliations

IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression

C D DiNardo et al. Leukemia. 2016 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosure: The authors declare no competing interests.

Figures

Figure 1
Figure 1
a: OS of treatment-naïve MDS patients by IDH1/2-mutant versus wild-type b: PFS of treatment-naïve MDS patients by IDH1/2-mutant versus wild-type
See this image and copyright information in PMC

References

    1. Im AP, Sehgal AR, Carroll MP, Smith BD, Tefferi A, Johnson DE, et al. DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, UK. 2014 Sep;28(9):1774–83. - PMC - PubMed
    1. DiNardo CD, Ravandi F, Agresta S, Konopleva M, Takahashi K, Kadia T, et al. Characteristics, clinical outcome and prognostic significance of IDH mutations in AML. American journal of hematology. 2015 May 27; - PMC - PubMed
    1. Pardanani A, Patnaik MM, Lasho TL, Mai M, Knudson RA, Finke C, et al. Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q) Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, UK. 2010 Jul;24(7):1370–2. - PubMed
    1. Kosmider O, Gelsi-Boyer V, Slama L, Dreyfus F, Beyne-Rauzy O, Quesnel B, et al. Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, UK. 2010 May;24(5):1094–6. - PubMed
    1. Thol F, Weissinger EM, Krauter J, Wagner K, Damm F, Wichmann M, et al. IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis. Haematologica. 2010 Oct;95(10):1668–74. - PMC - PubMed

Publication types